Novacyt has launched a diagnostic test for the new strain of coronavirus, which originated in Wuhan and has spread worldwide, leading the World Health Organization (WHO) to declare a global health emergency.

Novacyt stock soared 32% on Friday morning after the French cellular diagnostics company announced the launch of a new test for the coronavirus.

The test has been developed as a direct response to the recent outbreak of the new strain of coronavirus, which originated in the Chinese city of Wuhan and has now spread worldwide, leading the World Health Organization (WHO) to declare a global health emergency.

The death toll has now hit 213 with confirmed cases rising to 9,692, according to Chinese health officials. Coronaviruses are a large family of viruses that usually infect animals but can sometimes evolve and spread to humans. The new test is able to detect only the 2019 strain of the virus, reducing the risk of a false diagnosis, the company said in a statement.

The test, generated by the company’s Primerdesign molecular diagnostics team, can also generate a result in less than two hours, enabling samples to be screened quickly, which the company says could help prevent the “unnecessary” spread of the virus.

To read the full article, please click here.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Spotify
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound